本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BOTANIX PHARMACEUTICALS LTD

0.020
0.000
成交量:2,564.67萬
成交額:49.17萬
市值:5,468.63萬
市盈率:-0.43
高:0.020
開:0.019
低:0.018
收:0.020
52周最高:0.350
52周最低:0.018
股本:27.34億
流通股本:17.18億
量比:2.18
換手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):-0.046
每股收益(LYR):-0.047
淨資產收益率:-121.11%
總資產收益率:-53.38%
市淨率:1.01
市盈率(LYR):-0.43

資料載入中...

公司資料

公司名字:
BOTANIX PHARMACEUTICALS LTD
交易所:
ASX
成立時間:
1984
員工人數:
11
公司地址:
Tower 5, Collins Square,Level 23,727 Collins Street,Melbourne,Western Australia,Australia
郵編:
3008
傳真:
61 8 6210 1153
簡介:
Botanix Pharmaceuticals Limited, a clinical stage cannabinoid therapeutics company, develops therapeutics for serious skin diseases in Australia. It offers BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1308, a transdermal gel formulation for the treatment of plaque psoriasis; BTX 1204, a transdermal gel formation for the treatment of atopic dermatitis; BTX 1701, a novel product for mild acne; and BTX 1801, a novel antimicrobial. The company is based in North Perth, Australia.